Good MorningEquity markets drifted higher on Thursday, buoyed by Walmart's results despite a cautious outlook. The retailer reported a better-than-expected quarter and reaffirmed guidance, stating consumers would begin to feel the impact of tariffs by the end of the current quarter.
The S&P 500 is poised to retest record highs, but whether conditions are strong enough to push it further may hinge on NVIDIA’s upcoming Q1 earnings report later this month. Featured: Gold Is Soaring and this Fund Let's You Collect Monthly (Ad) 
|
Stocks | | Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set just a few months earlier, though it may feel like an economic era ago. The S&P 500 rose 0.7% for a fifth straight gain and closed out its third winning week in the last fo... Read the Full Story |
|
From Our Partners | | As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC.
Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever.
But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs…
Paving the way for Elon Musk's secret master plan. | Click here to see how to claim your stake before they launch to avoid missing out. |
|
Markets | | Shares were mixed Friday in Asia after Wall Street drifted higher as reports suggested the Federal Reserve may have more leeway to cut interest rates later this year to support the U.S. economy if it weakens under the weight of President Donald Trump's high tariffs. U.S. futures and oil prices were ... Read the Full Story |
|
Markets | | U.S. applications for jobless benefits held steady last week as layoffs remain low despite uncertainty over how President Donald Trump’s tariffs will impact the economy.The number of Americans applying for unemployment aid was unchanged at 229,000 for the week ending May 10, the Labor Department sai... Read the Full Story |
|
From Our Partners | | The media and financial pundits are all misreading Trump’s actions.
They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals…
They think his involvement in Ukraine is just another resource grab…
They think his tariffs will wreck the economy…
But they’re all missing the bigger picture. | This is fast becoming the world’s most sought-after resource. |
|
Markets | |
Microsoft Corporation (NASDAQ: MSFT) and OpenAI have announced that they are looking to reset their partnership. The reset is the latest chapter in a story that’s been building between the two companies for the last six years. In this case, it should be profitable for MSFT sto... Read the Full Story |
|
Markets | | The United Nations on Thursday forecast slower global economic growth this year and next, pointing to the impact of the surge in U.S. tariffs and increasing trade tensions.U.N. economists also cited the volatile geopolitical landscape and threats of rising production costs, supply chain disruptions ... Read the Full Story |
|
From Our Partners | | The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and ushering in more economic uncertainty.
Claim your FREE AI & Gold Report today and learn what central banks, investors, and analysts are seeing—and how gold can help protect your savings in an uncertain, AI-driven world. | ▻ Get ahead of the trend—CLICK HERE to claim your FREE AI & Gold Report now! |
|
Markets | |
Despite mounting challenges in 2025, Wall Street and institutional investors continue to express strong confidence in Alphabet (NASDAQ: GOOGL).
While the stock has faced significant pressure this year, Alphabet is at a technical and fundamental turning point.
After bouncing off supp... Read the Full Story |
|
Markets | |
Average investors focus on the next year or two for a company they consider buying for their portfolios, but those who can keep a longer time horizon in mind stand out above the crowd. There are several examples of legendary value investors who don’t often move their money around, but every ... Read the Full Story |
|
Markets | |
Over approximately the last three weeks, markets have been on the rise big-time. The S&P 500 closed just under $5,900 on May 14, just around 4% lower than the all-time high it reached in February. As market sentiment shifts, Broadcom (NASDAQ: AVGO), a leading semiconductor stock, has em... Read the Full Story |
|
Markets | | The Japanese economy contracted at an annual rate of 0.7% in the first quarter, according to government data released Friday, as U.S. President Donald Trump’s trade war hurt exports and dented consumer confidence. Japan’s real gross domestic product, or the measure of a nation’s goods and services, ... Read the Full Story |
|
Markets | |
Walmart’s (NYSE: WMT) stock price is set for a big move due to underlying strengths, market positioning, guidance, high potential for positive catalysts, and analysts' sentiment.
The analysts' sentiment trends ahead of the FQ1 2026 earnings report were bullish, leading this mark... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts. | View Today's Stock Pick |
|